RJA
OGI

Raymond James & Associates’s Organigram Holdings OGI Stock Holding History

Raymond James & Associates’s Portfolio OGI Stock Details OGI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,618
Closed -$17K – 4160
2022
Q1 		$17K Sell
2,618
-1,339
-34% -$8.26K ﹤0.01% 4021
2021
Q4 		$28K Sell
3,957
-8,093
-67% -$68.7K ﹤0.01% 4003
2021
Q3 		$111K Buy
12,050
+865
+8% +$8.86K ﹤0.01% 3818
2021
Q2 		$128K Buy
11,185
+5,161
+86% +$58.8K ﹤0.01% 3791
2021
Q1 		$83K Buy
6,024
+821
+16% +$9.49K ﹤0.01% 3802
2020
Q4 		$28K Buy
5,203
+1,959
+60% +$10.1K ﹤0.01% 3666
2020
Q3 		$14K Buy
3,244
+200
+7% +$1.04K ﹤0.01% 3526
2020
Q2 		$19K Sell
3,044
-104
-3% -$700 ﹤0.01% 3444
2020
Q1 		$25K Sell
3,148
-1,885
-37% -$17.1K ﹤0.01% 3382
2019
Q4 		$49K Buy
+5,033
New +$59.4K ﹤0.01% 3552

Other funds holding OGI

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MC
Merlin Capital Newport, Rhode Island $33.5M AUM 36.34% 1-Year Est. Return
IIM
Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Raymond James & Associates's OGI Position: Q2 2022 in Review

Raymond James & Associates sold out of Organigram Holdings (OGI) in Q2 2022, closing a stake of 2,618 shares — an estimated $17K sold.

Raymond James & Associates first reported a position in OGI in Q4 2019 and held it in 10 quarters. The position peaked at $128K in Q2 2021. 141 funds tracked by Wall St. Rank hold OGI as of Q2 2022.

  • Raymond James & Associates reported no remaining Organigram Holdings position as of Q2 2022 after selling out during the quarter.
  • Raymond James & Associates sold 2,618 Organigram Holdings shares in Q2 2022, an estimated $17K.
  • Raymond James & Associates first reported a position in Organigram Holdings in Q4 2019 and held it in 10 quarters.
  • Raymond James & Associates's Organigram Holdings position peaked at $128K in Q2 2021.
  • 141 funds tracked by Wall St. Rank held Organigram Holdings as of Q2 2022.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.